Age-Related Kynurenine Accumulation Impairs miRNA and Hdac Epigenetic Regulation of the SDF-1 Axis Resulting in Bone Loss

与年龄相关的犬尿氨酸积累损害 SDF-1 轴的 miRNA 和 Hdac 表观遗传调节,导致骨质流失

基本信息

  • 批准号:
    10375583
  • 负责人:
  • 金额:
    $ 49.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-15 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

The mechanisms involved in aging-related osteoporosis remain poorly defined, however, recent studies from our group, and others, suggest that it is a stem cell disease. We have been studying the role of the cytokine SDF-1 (CXCL12) and Hdac3 in bone marrow mesenchymal stem/stromal cell (BMSC) function and bone homeostasis. A critical problem is that aging triggers impaired localization, proliferation, survival, and differentiation of the osteogenic progenitor cell population in the bone marrow (BM), specifically BMSCs. A critical barrier to preventing these changes is identifying key regulatory pathways, and being able to alter or correct them. We have identified BMSC epigenetic changes in the microRNA miR-29b-1-5p, that appears to cross-talk with histone deacetylase 3 (Hdac3), a second epigenetic regulatory system. Further, we have identified that the oxidized tryptophan (TRP) metabolite kynurenine (KYN) alters these specific epigenetic regulatory molecules in BMSCs, which in turn directly, and via SDF-1 signaling pathways, affect cell survival, osteogenesis, osteoblastic lipid storage, and bone formation. Significantly, miR-29b-1-5p, which increases with aging in BMSCs, belongs to the miR29 family of miRNAs that have been shown to be critical in extracellular matrix homeostasis and osteogenesis. One novel aspect is that miR29b-1-5p is the “passenger strand”, which is normally thought to be degraded leaving the complementary miR-29b-1-3p “guide strand” as the functional miRNA; with aging, however, our data suggest that this passenger strand is an important effector of BMSC dysfunction. Importantly, miR-29b- 1-5p, which targets SDF-1, is upregulated by KYN while Hdac3 is down regulated leading to increased lipid storage and dysfunction in BM osteoprogenitor cells and OBs. Understanding the upstream mechanisms that drive these previously unknown age-associated changes in miR-29b-1-5p and Hdac3 is a critical goal because we have demonstrated that these two interacting systems regulate SDF-1 expression and suppress BMSC osteogenesis and survival pathways while increasing BM fat storage. We propose to test the hypothesis that the elevated, age-related levels of KYN drive the increased expression of miR-29b-1-5p and inhibition of Hdac3 expression, with downstream effects on bone homeostasis via SDF-1 and its receptor CXCR4, or directly by targeting additional osteogenic genes both in BMSCS and OBs. Our objectives are to test new hypotheses derived from our findings by manipulating the miRNAs and Hdacs we identified as changing with age in human/murine BMSCs to determine their effects on bone formation and turnover in vivo and at the molecular level on BMSC osteogenic function. We will test novel methods to reduce expression of these molecules, including inhibiting KYN generation, inhibiting KYN signaling pathways, or delivering synthetic anti-miRNAs to inhibit miR29b-1-5p. The impact of this project will be to clarify the roles of age-associated epigenetic changes in cross-talking BMSC miRNA and Hdac systems with the goal of identifying novel targets for reducing, or reversing, age-related bone loss and osteoporosis.
然而,我们最近的研究表明,与衰老相关的骨质疏松症的机制仍然不明确

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WILLIAM D HILL其他文献

WILLIAM D HILL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WILLIAM D HILL', 18)}}的其他基金

Age-Related Kynurenine Accumulation Impairs miRNA and Hdac Epigenetic Regulation of the SDF-1 Axis Resulting in Bone Loss
与年龄相关的犬尿氨酸积累损害 SDF-1 轴的 miRNA 和 Hdac 表观遗传调节,导致骨质流失
  • 批准号:
    9973283
  • 财政年份:
    2020
  • 资助金额:
    $ 49.27万
  • 项目类别:
Kynurenine Pathway Regulation of CNS Senescence in Alzheimer's Disease Pathology
阿尔茨海默病病理学中中枢神经系统衰老的犬尿氨酸途径调节
  • 批准号:
    10713140
  • 财政年份:
    2020
  • 资助金额:
    $ 49.27万
  • 项目类别:
Age-Related Kynurenine Accumulation Impairs miRNA and Hdac Epigenetic Regulation of the SDF-1 Axis Resulting in Bone Loss
与年龄相关的犬尿氨酸积累损害 SDF-1 轴的 miRNA 和 Hdac 表观遗传调节,导致骨质流失
  • 批准号:
    10216949
  • 财政年份:
    2020
  • 资助金额:
    $ 49.27万
  • 项目类别:
Age-Related Kynurenine Accumulation Impairs miRNA and Hdac Epigenetic Regulation of the SDF-1 Axis Resulting in Bone Loss
与年龄相关的犬尿氨酸积累损害 SDF-1 轴的 miRNA 和 Hdac 表观遗传调节,导致骨质流失
  • 批准号:
    10609892
  • 财政年份:
    2020
  • 资助金额:
    $ 49.27万
  • 项目类别:
Bad to the Bone: Age-related Increases in Serum SDF-1 Leads to Bone Loss with Age
对骨骼有害:血清 SDF-1 随年龄增长而增加,导致骨质流失
  • 批准号:
    8810590
  • 财政年份:
    2014
  • 资助金额:
    $ 49.27万
  • 项目类别:
Bad to the Bone: Age-related Increases in Serum SDF-1 Leads to Bone Loss with Age
对骨骼有害:血清 SDF-1 随年龄增长而增加,导致骨质流失
  • 批准号:
    8967197
  • 财政年份:
    2014
  • 资助金额:
    $ 49.27万
  • 项目类别:
NEUROFILAMENT INVOLVEMENT IN LEWY BODY DISORDERS
神经丝参与路易体疾病
  • 批准号:
    2271299
  • 财政年份:
    1994
  • 资助金额:
    $ 49.27万
  • 项目类别:
NEUROFILAMENT INVOLVEMENT IN LEWY BODY DISORDERS
神经丝参与路易体疾病
  • 批准号:
    2416348
  • 财政年份:
    1994
  • 资助金额:
    $ 49.27万
  • 项目类别:
NEUROFILAMENT INVOLVEMENT IN LEWY BODY DISORDERS
神经丝参与路易体疾病
  • 批准号:
    2271297
  • 财政年份:
    1994
  • 资助金额:
    $ 49.27万
  • 项目类别:
NEUROFILAMENT INVOLVEMENT IN LEWY BODY DISORDERS
神经丝参与路易体疾病
  • 批准号:
    2271298
  • 财政年份:
    1994
  • 资助金额:
    $ 49.27万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

A randomized, double-blind, placebo-controlled, clinical trial of a probiotic/prebiotic supplement for the dietary management of age-related bone loss.
益生菌/益生元补充剂用于饮食管理与年龄相关的骨质流失的随机、双盲、安慰剂对照临床试验。
  • 批准号:
    10733549
  • 财政年份:
    2023
  • 资助金额:
    $ 49.27万
  • 项目类别:
Doctoral Dissertation Research: Exploring Localized Relationships Between Age-related Bone Loss and Cortical Expansion in Diaphyseal Bone
博士论文研究:探索年龄相关骨丢失与骨干皮质扩张之间的局部关系
  • 批准号:
    2141878
  • 财政年份:
    2022
  • 资助金额:
    $ 49.27万
  • 项目类别:
    Standard Grant
Influence of aging on the preB cell product, λ5, and its contribution to age-related bone loss
衰老对前 B 细胞产物 α5 的影响及其对与年龄相关的骨质流失的贡献
  • 批准号:
    10589513
  • 财政年份:
    2022
  • 资助金额:
    $ 49.27万
  • 项目类别:
Regulation of age-related bone loss by PKIgamma
PKIgamma 调节与年龄相关的骨质流失
  • 批准号:
    10208697
  • 财政年份:
    2020
  • 资助金额:
    $ 49.27万
  • 项目类别:
Regulation of age-related bone loss by PKIgamma
PKIgamma 调节与年龄相关的骨质流失
  • 批准号:
    10399612
  • 财政年份:
    2020
  • 资助金额:
    $ 49.27万
  • 项目类别:
Regulation of age-related bone loss by PKIgamma
PKIgamma 调节与年龄相关的骨质流失
  • 批准号:
    10615740
  • 财政年份:
    2020
  • 资助金额:
    $ 49.27万
  • 项目类别:
Effect of tea flavonoids and low dose estrogen on bone metabolism in an animal model for age-related bone loss
茶黄酮和低剂量雌激素对年龄相关性骨质流失动物模型骨代谢的影响
  • 批准号:
    488140-2016
  • 财政年份:
    2018
  • 资助金额:
    $ 49.27万
  • 项目类别:
    Postdoctoral Fellowships
Effect of tea flavonoids and low dose estrogen on bone metabolism in an animal model for age-related bone loss
茶黄酮和低剂量雌激素对年龄相关性骨质流失动物模型骨代谢的影响
  • 批准号:
    488140-2016
  • 财政年份:
    2017
  • 资助金额:
    $ 49.27万
  • 项目类别:
    Postdoctoral Fellowships
Development of a Wearable Electrical Stimulation Device to Mitigate Age-Related Bone Loss
开发可穿戴电刺激装置以减轻与年龄相关的骨质流失
  • 批准号:
    515665-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 49.27万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Risk Factors for Age Related Bone Loss
年龄相关骨质流失的危险因素
  • 批准号:
    9539088
  • 财政年份:
    2017
  • 资助金额:
    $ 49.27万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了